Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04451421
Other study ID # transpulmonary pressure
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 1, 2020
Est. completion date October 1, 2021

Study information

Verified date June 2020
Source Chinese PLA General Hospital
Contact Zhao Ying
Phone 17600953801
Email 1412888703@qq.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Effects of standing at different angles on transpulmonary pressure


Description:

Objective: To study the effect of different standing angles on cross-lung pressure.Background: Long-term bed rest in ICU patients leads to upward movement of diaphragm and increased intrathoracic pressure in mechanically ventilated patients, resulting in lower cross-lung pressure. If the end-expiratory cross-lung pressure is negative, lung tissue compression and atelectasis will occur.Standing can lower the diaphragm, improve the pressure across the lungs, and improve ventilation.Selection methods: patients with invasive mechanical ventilation in the ICU, on the premise of stable hemodynamics, with the aid of electric bed training in standing in different angles, start from 20 degrees, 5 degrees up every five minutes, the largest up to 80 degrees, each Angle across the pulmonary pressure, die cavity ratio, tidal volume and breathe out carbon dioxide at the end of the record, and record whether low blood pressure, an accident in the process of take off the tube and other adverse reactions.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date October 1, 2021
Est. primary completion date October 1, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 95 Years
Eligibility Inclusion Criteria:

- The age is = 18 years old;

- the hemodynamics is stable;

- 50 < heart rate < 120 beats / min ;

- 90 < systolic blood pressure < 200mmHg ;

- 55 < mean arterial pressure < 120mmHg;

- do not increase the dose of pressor drugs for at least 2 hours;

- intracranial pressure is stable and there are no seizures within 24 hours;

- the respiratory state is stable;

- the patient's finger pulse oxygen saturation = 88%;

- 10 < respiratory frequency < 35 beats / min.

Exclusion Criteria:

- Pregnancy;

- acute cardio-cerebrovascular events;

- spinal or limb fractures;

- active bleeding.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Change of standing Angle
Change the patient's standing Angle by using an electric bed

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Chinese PLA General Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary transpulmonary pressure End-expiratory pressure across the lungs is recommended at 0-5cmH2O. 5 minutes
Primary Esophageal pressure The change in esophageal pressure represents the degree of inspiratory effort.The greater the variation, the harder the inhale. 5 minutes
Primary Dead space rate the smaller,the better 5 minutes
Primary tidal volume Standard tidal volume: standard weight based on height, 6 to 8ml per kg body weight 5 minutes
Primary partial pressure of carbon dioxide in endexpiratory gas The smaller the difference between pCO2 and arterial blood gas, the better 5 minutes
Secondary adverse reaction hypotension?Accident to take off the tube?Drop of bed,Record the number of times it happens.The more it happens, the less safe it is. an hour
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03572335 - Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)
Recruiting NCT06088485 - The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
Terminated NCT03309358 - A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis Phase 1
Active, not recruiting NCT02504697 - DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer
Completed NCT01443845 - Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS) Phase 4
Terminated NCT00524095 - Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis Phase 2
Completed NCT00210249 - Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment
Completed NCT00023114 - p450 Mediated Lung Toxicity N/A
Recruiting NCT06056882 - Simultaneous CLE Guided Crybiopsy in Patients With Pulmonary Nodules
Completed NCT03994848 - Incentive Spirometry Prehabilitation Study N/A
Completed NCT00366509 - Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
Withdrawn NCT05100160 - Gabapentin for the Reduction of Opiate Use Following Pulmonary Resection (GROUP Trial) Phase 3
Completed NCT03229473 - Fall Risk Assessment in COPD
Recruiting NCT04767074 - A Non-pharmacological Cough Control Therapy N/A
Not yet recruiting NCT03899298 - Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions Phase 1
Completed NCT04996693 - On Dose Efficiency of Modern CT-scanners in Chest Scans N/A
Recruiting NCT04996173 - Cryospray Therapy Versus Standard of Care for Benign Airway Stenosis (CryoStasis) N/A
Completed NCT04601545 - The Virtual Reality Therapy as a Pulmonary Rehabilitation Supporting Method N/A
Recruiting NCT03937583 - Screening for Cancer in Patients With Unprovoked VTE Phase 4
Recruiting NCT02862418 - Imaging of Lungs With a New Type of Magnetic Resonance Imaging (MRI) Called UTE (Ultrashort Echo Time)